Image For Activity Cover
ORN Spring 2024 - Maternal Morbidity and Mortality Associated with Methamphetamine and Other Substance Use in the Perinatal Period
AVAILABLE ON-DEMAND
Available on-demand. Login or create an account to register to view the recording.
Description:

This lecture will describe how the trajectory of substance use and substance use disorders intersects with pregnancy and postpartum period including increased risk of morbidity and mortality.

Some evidence-informed treatments for methamphetamine use disorders among pregnant and postpartum people will be discussed.
Learning objectives:
At the conclusion of this seminar, attendees should be able to:
  1. Describe how the trajectory of substance use and substance use disorders intersects with pregnancy and postpartum period including increased risk of morbidity and mortality 
  2. Describe some evidence-informed treatments for methamphetamine use disorders among pregnant and postpartum people.
Instructions and Claiming CME
What is ORN
Speaker:
Marcela Smid MD, MA, MS

Marcela Smid MD, MA, MS is a board certified Maternal Fetal Medicine and Addiction Medicine physician at the University of Utah. She is the director of perinatal addiction services and the medical director of the Substance Use & Pregnancy - Recovery, Addiction, Dependence (SUPeRAD) specialty prenatal clinic, a multi-disciplinary clinic for pregnant and postpartum women with substance use disorder. She recently took over as Chair of the Utah Maternal Mortality Committee. Her research focus is on perinatal addiction, interventions for pregnant and postpartum women with substance use disorders, maternal mortality and maternal mental health.
DISCLAIMER

ACCREDITATION:
This actvity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association and The American Osteopathic Academy of Addiction Medicine (AOAAM). The American Osteopathic Association is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT HOURS:
The American Osteopathic Association designates this other activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION:
All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.

Funding:

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Summary
Availability: No future session
Expires on Mar 01, 2027
Cost: FREE
Credit Offered:
1 AMA PRA Category 1 Credit
1 AOA Category 1A Credit
Recommended
Powered By